![]() Its Generic Pharmaceuticals segment consists of a product portfolio including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics and sprays. Its Sterile Injectables segment consists of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection, among others. Strides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 3026. Endo Pharmaceutical Blogs, Comments and Archive News on. The revenue is the total amount of income that a company generates by the sale of goods or services. In 2022 the company made a revenue of 2.31 B a decrease over the years 2021 revenue that were of 2.99 B. Its products include XIAFLEX, SUPPRELIN LA, NASCOBAL Nasal Spray, AVEED, QWO, PERCOCET, TESTOPEL, EDEX and LIDODERM, among others. Endo Pharmaceutical Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. According to Endo International 's latest financial reports the company's current revenue (TTM) is 2.18 B. ![]() For companies with multiple common share classes, market. Its Branded Pharmaceuticals segment includes a variety of branded products in the areas of urology, orthopedics, endocrinology, medical aesthetics and bariatrics, among others. Market Cap is calculated by multiplying the number of shares outstanding by the stocks price. The Company operates through four business segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. Two Affiliate Companies Joined Endo International plc BankruptcyĮarnings Flash (ENDPQ) ENDO INTERNATIONAL Reports Q1 Adjusted EPS $0.Endo International plc is a specialty pharmaceutical company. Premier Forms Pitocin Supply Partnership With Endo InternationalĮndo International plc Launches First Generic Version of Noxafil® (posaconazole) InjectionĮndo International plc Announces Approval of XCOPRI (Cenobam Tablets) in CanadaĮndo International plc Announces First Patient Enrolled in Registry of Dupuytren's ContractureĮndo International plc Launches Dexlansoprazole Capsules, Generic Version of DexilantĮndo International plc Launches PREVDUO (Neostigmine Mylsulfate and Glycopyrrolate Injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe Overview Stock Screener Earnings Calendar Sectors ENDPQ U.S.: OTC Endo International PLC Watch list Closed Last Updated: 3:26 p.m. Second Motion for Exclusivity Period Extension Approved For Endo International plcīankrupt Endo says US government objections imperil $600 million in opioid settlements Endo International (ENDP) reported Q3 2022 earnings per share (EPS) of -3.07, missing estimates of 0.37 by 927.76. 25, 2021 /PRNewswire/ - Endo International plc (NASDAQ: ENDP) announced today the launch of their first-ever XIAFLEX ® (collagenase clostridium histolyticum) television commercial, Bent Carrot. ![]() Tranche Update on Endo International plc (OTCPK:ENDP.Q)'s Equity Buyback Plan announced on April 30, 2015.Įarnings Flash (ENDP) ENDO INTERNATIONAL Posts Q2 Revenue $547MĮarnings Flash (ENDP) ENDO INTERNATIONAL Reports Q2 EPS $0.98Įndo International plc Revises Earnings Guidance for the Year 2023Įndo International plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 The Investor Relations website contains information about Endo International plc s business for stockholders, potential investors, and financial analysts.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |